RARRES1-RSRC1 Fusion FISH Probe
The RARRES1-RSRC1 Fusion FISH Probe is used to confirm a fusion of the RARRES1 and RSRC1 genes. The fusion of the RARRES1 and RSRC1 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RARRES1-RSRC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RARRES1-RSRC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
RARRES1 Gene Summary
This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
Gene Name: Retinoic Acid Receptor Responder 1
Chromosome: CHR3: 158414896 -158450275
Locus: 3q25.32
RSRC1 Gene Summary
This gene encodes a member of the serine and arginine rich-related protein family. The encoded protein is involved in both constitutive and alternative mRNA splicing. This gene may be associated with schizophrenia. A pseudogene of this gene is located on chromosome 9. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Nov 2012]
Gene Name: Arginine And Serine Rich Coiled-coil 1
Chromosome: CHR3: 157827891 -158262576
Locus: 3q25.32
Gene Diseases
The RARRES1 RSRC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|